BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15896447)

  • 1. Risk assessment of chemicals and pharmaceuticals in the pediatric population: a workshop report.
    Pohl HR; van Engelen JG; Wilson J; Sips AJ
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):83-95. PubMed ID: 15896447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric pharmacokinetic data: implications for environmental risk assessment for children.
    Ginsberg G; Hattis D; Miller R; Sonawane B
    Pediatrics; 2004 Apr; 113(4 Suppl):973-83. PubMed ID: 15060190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of the workshop on the power of aggregated toxicity data.
    Woodall GM; Goldberg RB
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):71-5. PubMed ID: 19013305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals.
    Küster A; Bachmann J; Brandt U; Ebert I; Hickmann S; Klein-Goedicke J; Maack G; Schmitz S; Thumm E; Rechenberg B
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):276-80. PubMed ID: 19607869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of biokinetics in risk assessment of drugs and chemicals in children.
    de Zwart LL; Haenen HE; Versantvoort CH; Wolterink G; van Engelen JG; Sips AJ
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):282-309. PubMed ID: 15135209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of drugs, biologics and therapeutic devices: present and future issues.
    Centers for Education and Research on Therapeutics Risk Assessment Workshop
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):653-62. PubMed ID: 14762981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children as a vulnerable population.
    Landrigan PJ
    Int J Occup Med Environ Health; 2004; 17(1):175-7. PubMed ID: 15212221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental exposure assessment, pollution sources, and exposure agents: a primer for pediatric nursing professionals.
    Shendell DG; Pike-Paris A
    Pediatr Nurs; 2007; 33(2):179-82. PubMed ID: 17542241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
    Besse JP; Garric J
    Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling exposure to persistent chemicals in hazard and risk assessment.
    Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
    Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues.
    Neri M; Bonassi S; Knudsen LE; Sram RJ; Holland N; Ugolini D; Merlo DF
    Mutat Res; 2006 Jan; 612(1):1-13. PubMed ID: 16002329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurses' role in children's environmental health protection.
    Sattler B; Davis del BA
    Pediatr Nurs; 2008; 34(4):329-39. PubMed ID: 18814568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical laboratory investigation of children's environmental health.
    Hoffman HE; Buka I; Phillips S
    Pediatr Clin North Am; 2007 Apr; 54(2):399-415, x. PubMed ID: 17448366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on environmental risk assessment of drugs: excretion forms to environment].
    Hirata-Koizumi M; Saito M; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2006; (124):83-6. PubMed ID: 17405530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling approaches for estimating the dosimetry of inhaled toxicants in children.
    Ginsberg GL; Asgharian B; Kimbell JS; Ultman JS; Jarabek AM
    J Toxicol Environ Health A; 2008; 71(3):166-95. PubMed ID: 18097944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential new approaches for children's inhalation risk assessment.
    Firestone M; Sonawane B; Barone S; Salmon AG; Brown JP; Hattis D; Woodruff T
    J Toxicol Environ Health A; 2008; 71(3):208-17. PubMed ID: 18097946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.